Objectives:
To furnish scientific solutions for mycobacterial diseases and associated conditions.
To conduct top science aimed at breakthroughs in disease control.
To elevate the proficiency of researchers in this domain and foster the development of human resources.
About Us:
Mycobacterial Diseases Panel
Message from the Chairs
We are pleased to announce the opening of this website with the aim of reducing the distance between researchers in the U.S., Japan, and Asia, encouraging beneficial collaboration, and promoting understanding and, ultimately, the control of mycobacteria and mycobacterial diseases.
The following contents are included in this website.
Information about researchers and laboratories of mycobacteria and mycobacterial diseases
Applicable research funds
Press releases of Research Results
Consultation service for joint research proposals and research
Information about mycobacterial diseases
Information about the research meetings and conferences
The USJ CMSP-Mycobacterial Diseases Division will manage this website, but it can be used not only by basic researchers and clinicians but also by the general public and government officials.
We hope this website will promote international communications and the understanding and control of mycobacterial diseases.
January 2024
Sabine Ehrt, US Side Chair
Sohkichi Matsumoto, Japan Side Chair
Since its inception in 1965, two independent panels, one for tuberculosis and one for leprosy, were merged into the 'Tuberculosis and Leprosy Panel' in 1996. On its 50th anniversary in 1995, the name was changed to the 'Mycobacterial Diseases Panel', which remains to this day.
Since 2013, the Antimicrobial Diseases Subcommittee has continued to interact at the biennial International Conference on Emerging Infectious Diseases in the Pacific Rim (EID) and, in years when there is no EID conference, at the Subcommittee's own U.S.-Japan Cooperative Medical Science Program, Mycobacteria Panel Meetings (Japan-US Joint Panel Meeting) has contributed to the promotion of research and disease control. The US-Japan Cooperative Medical Science Program will celebrate its 60th anniversary in 2025.
On the other hand, as described in a separate section, mycobacterial diseases remain life-threatening pathogens, and non-tuberculous mycobacteriosis is still intractable and has an incurable aspect. Leprosy also significantly reduces people's quality of life in some areas. Under these circumstances, the 'Mycobacterial Diseases Panel' is expected to continue to play a significant role in research exchange, human resource development and the implementation of top science to generate breakthroughs in disease control.
